Atom Investors’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-18,335
Closed -$470K 351
2021
Q1
$470K Buy
+18,335
New +$460K 0.08% 157

Other funds holding RNLX

Atom Investors's RNLX Position: Q2 2021 in Review

Atom Investors sold out of Renalytix plc American Depositary Shares (RNLX) in Q2 2021, closing a stake of 18,335 shares — an estimated $470K sold.

Atom Investors first reported a position in RNLX in Q1 2021 and held it in 1 quarter. The position peaked at $470K in Q1 2021. 41 funds tracked by Wall St. Rank hold RNLX as of Q2 2021.

  • Atom Investors reported no remaining Renalytix plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Atom Investors sold 18,335 Renalytix plc American Depositary Shares shares in Q2 2021, an estimated $470K.
  • Atom Investors first reported a position in Renalytix plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
  • Atom Investors's Renalytix plc American Depositary Shares position peaked at $470K in Q1 2021.
  • 41 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q2 2021.

Based on Atom Investors's 13F filing for Q2 2021, filed 16 Aug 2021.